Shares Held by Insiders

Fully Diluted Shares Held by Insiders

Date

Name

Buy/Sell

$ Value

# Shares

Avg. Price

Title

Chief Executive Officer

Chief Scientific Officer

Chief Financial Officer

MoonLake Immunotherapeutics, a clinical-stage biopharmaceutical company, engages in developing therapies. It is developing Sonelokimab, a novel investigational Nanobody for the treatment of inflammation diseases. The company is involved in conducting Phase II trials for hidradenitis suppurativa, psoriatic arthritis, ankylosing spondylitis, or axial spondyloarthritis. MoonLake Immunotherapeutics was incorporated in 2021 and is headquartered in Zug, Switzerland.

MoonLake Immunotherapeutics, a clinical-stage biopharmaceutical company, engages in developing therapies.

Datesorted ascending	Name	Buy/Sell	$ Value	# Shares	Avg. Price	Title
2024-02-29	Premium	sold	Premium	Premium	Premium	Chief Executive Officer
2024-02-28	Premium	sold	Premium	Premium	Premium	Chief Scientific Officer
2024-02-28	Premium	sold	Premium	Premium	Premium	Chief Scientific Officer
2024-02-28	Premium	sold	Premium	Premium	Premium	Chief Executive Officer
2024-02-27	Premium	sold	Premium	Premium	Premium	Chief Scientific Officer
2024-02-27	Premium	sold	Premium	Premium	Premium	Chief Scientific Officer
2024-02-27	Premium	sold	Premium	Premium	Premium	Chief Executive Officer
2024-02-21	Premium	sold	Premium	Premium	Premium	Chief Executive Officer
2024-02-21	Premium	sold	Premium	Premium	Premium	Chief Scientific Officer
2024-02-21	Premium	sold	Premium	Premium	Premium	Chief Scientific Officer
2024-02-20	Premium	sold	Premium	Premium	Premium	Chief Scientific Officer
2024-02-20	Premium	sold	Premium	Premium	Premium	Chief Executive Officer
2024-02-20	Premium	sold	Premium	Premium	Premium	Chief Scientific Officer
2024-02-16	Premium	sold	Premium	Premium	Premium	Chief Executive Officer
2024-02-16	Premium	sold	Premium	Premium	Premium	Chief Scientific Officer
2024-02-15	Premium	sold	Premium	Premium	Premium	Chief Executive Officer
2024-02-15	Premium	sold	Premium	Premium	Premium	Chief Scientific Officer
2024-02-15	Premium	sold	Premium	Premium	Premium	Chief Scientific Officer
2024-02-14	Premium	sold	Premium	Premium	Premium	Chief Scientific Officer
2024-02-14	Premium	sold	Premium	Premium	Premium	Chief Scientific Officer
2023-12-20	Premium	sold	Premium	Premium	Premium	Chief Financial Officer
2023-12-19	Premium	sold	Premium	Premium	Premium	Chief Financial Officer
2023-10-05	Premium	bought	Premium	Premium	Premium	-
2023-10-04	Premium	bought	Premium	Premium	Premium	-

MLTX - MoonLake Immunotherapeutics Stock Price, Fair Value and News

Latest Insider Trading transactions for MLTX